Analysis of the Initiating Events in HIV-1 Particle Assembly and Genome Packaging
HIV-1 Gag drives a number of events during the genesis of virions and is the only viral protein required for the assembly of virus-like particles in vitro and in cells. Although a reasonable understanding of the processes that accompany the later stages of HIV-1 assembly has accrued, events that occur at the initiation of assembly are less well defined. In this regard, important uncertainties include where in the cell Gag first multimerizes and interacts with the viral RNA, and whether Gag-RNA interaction requires or induces Gag multimerization in a living cell. To address these questions, we developed assays in which protein crosslinking and RNA/protein co-immunoprecipitation were coupled with membrane flotation analyses in transfected or infected cells. We found that interaction between Gag and viral RNA occurred in the cytoplasm and was independent of the ability of Gag to localize to the plasma membrane. However, Gag:RNA binding was stabilized by the C-terminal domain (CTD) of capsid (CA), which participates in Gag-Gag interactions. We also found that Gag was present as monomers and low-order multimers (e.g. dimers) but did not form higher-order multimers in the cytoplasm. Rather, high-order multimers formed only at the plasma membrane and required the presence of a membrane-binding signal, but not a Gag domain (the CA-CTD) that is essential for complete particle assembly. Finally, sequential RNA-immunoprecipitation assays indicated that at least a fraction of Gag molecules can form multimers on viral genomes in the cytoplasm. Taken together, our results suggest that HIV-1 particle assembly is initiated by the interaction between Gag and viral RNA in the cytoplasm and that this initial Gag-RNA encounter involves Gag monomers or low order multimers. These interactions per se do not induce or require high-order Gag multimerization in the cytoplasm. Instead, membrane interactions are necessary for higher order Gag multimerization and subsequent particle assembly in cells.
Vyšlo v časopise:
Analysis of the Initiating Events in HIV-1 Particle Assembly and Genome Packaging. PLoS Pathog 6(11): e32767. doi:10.1371/journal.ppat.1001200
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001200
Souhrn
HIV-1 Gag drives a number of events during the genesis of virions and is the only viral protein required for the assembly of virus-like particles in vitro and in cells. Although a reasonable understanding of the processes that accompany the later stages of HIV-1 assembly has accrued, events that occur at the initiation of assembly are less well defined. In this regard, important uncertainties include where in the cell Gag first multimerizes and interacts with the viral RNA, and whether Gag-RNA interaction requires or induces Gag multimerization in a living cell. To address these questions, we developed assays in which protein crosslinking and RNA/protein co-immunoprecipitation were coupled with membrane flotation analyses in transfected or infected cells. We found that interaction between Gag and viral RNA occurred in the cytoplasm and was independent of the ability of Gag to localize to the plasma membrane. However, Gag:RNA binding was stabilized by the C-terminal domain (CTD) of capsid (CA), which participates in Gag-Gag interactions. We also found that Gag was present as monomers and low-order multimers (e.g. dimers) but did not form higher-order multimers in the cytoplasm. Rather, high-order multimers formed only at the plasma membrane and required the presence of a membrane-binding signal, but not a Gag domain (the CA-CTD) that is essential for complete particle assembly. Finally, sequential RNA-immunoprecipitation assays indicated that at least a fraction of Gag molecules can form multimers on viral genomes in the cytoplasm. Taken together, our results suggest that HIV-1 particle assembly is initiated by the interaction between Gag and viral RNA in the cytoplasm and that this initial Gag-RNA encounter involves Gag monomers or low order multimers. These interactions per se do not induce or require high-order Gag multimerization in the cytoplasm. Instead, membrane interactions are necessary for higher order Gag multimerization and subsequent particle assembly in cells.
Zdroje
1. HarrisonGP
LeverAM
1992
The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.
J Virol
66
4144
4153
2. LeverA
GottlingerH
HaseltineW
SodroskiJ
1989
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.
J Virol
63
4085
4087
3. LubanJ
GoffSP
1994
Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.
J Virol
68
3784
3793
4. CleverJ
SassettiC
ParslowTG
1995
RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1.
J Virol
69
2101
2109
5. FinziA
OrthweinA
MercierJ
CohenEA
2007
Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.
J Virol
81
7476
7490
6. JouvenetN
NeilSJ
BessC
JohnsonMC
VirgenCA
2006
Plasma membrane is the site of productive HIV-1 particle assembly.
PLoS Biol
4
e435
7. WelschS
KepplerOT
HabermannA
AllespachI
Krijnse-LockerJ
2007
HIV-1 buds predominantly at the plasma membrane of primary human macrophages.
PLoS Pathog
3
e36
8. BryantM
RatnerL
1990
Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.
Proc Natl Acad Sci U S A
87
523
527
9. GottlingerHG
SodroskiJG
HaseltineWA
1989
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
Proc Natl Acad Sci U S A
86
5781
5785
10. ZhouW
ParentLJ
WillsJW
ReshMD
1994
Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.
J Virol
68
2556
2569
11. SaadJS
MillerJ
TaiJ
KimA
GhanamRH
2006
Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Proc Natl Acad Sci U S A
103
11364
11369
12. SaadJS
LoeligerE
LuncsfordP
LirianoM
TaiJ
2007
Point mutations in the HIV-1 matrix protein turn off the myristyl switch.
J Mol Biol
366
574
585
13. OnoA
AblanSD
LockettSJ
NagashimaK
FreedEO
2004
Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane.
Proc Natl Acad Sci U S A
101
14889
14894
14. D'SouzaV
SummersMF
2005
How retroviruses select their genomes.
Nat Rev Microbiol
3
643
655
15. Ganser-PornillosBK
YeagerM
SundquistWI
2008
The structural biology of HIV assembly.
Curr Opin Struct Biol
18
203
217
16. MateuMG
2009
The capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly.
FEBS J
276
6098
6109
17. BriggsJA
SimonMN
GrossI
KrausslichHG
FullerSD
2004
The stoichiometry of Gag protein in HIV-1.
Nat Struct Mol Biol
11
672
675
18. MoritaE
SundquistWI
2004
Retrovirus budding.
Annu Rev Cell Dev Biol
20
395
425
19. BieniaszPD
2006
Late budding domains and host proteins in enveloped virus release.
Virology
344
55
63
20. CarltonJG
Martin-SerranoJ
2009
The ESCRT machinery: new functions in viral and cellular biology.
Biochem Soc Trans
37
195
199
21. HillCP
WorthylakeD
BancroftDP
ChristensenAM
SundquistWI
1996
Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly.
Proc Natl Acad Sci U S A
93
3099
3104
22. LeePP
LinialML
1994
Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
J Virol
68
6644
6654
23. ReilH
BukovskyAA
GelderblomHR
GottlingerHG
1998
Efficient HIV-1 replication can occur in the absence of the viral matrix protein.
EMBO J
17
2699
2708
24. WangCT
LaiHY
LiJJ
1998
Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.
J Virol
72
7950
7959
25. WangCT
ZhangY
McDermottJ
BarklisE
1993
Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.
J Virol
67
7067
7076
26. DorfmanT
BukovskyA
OhagenA
HoglundS
GottlingerHG
1994
Functional domains of the capsid protein of human immunodeficiency virus type 1.
J Virol
68
8180
8187
27. LiangC
HuJ
RussellRS
RoldanA
KleimanL
2002
Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag.
J Virol
76
11729
11737
28. ReicinAS
PaikS
BerkowitzRD
LubanJ
LowyI
1995
Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
J Virol
69
642
650
29. von SchwedlerUK
StrayKM
GarrusJE
SundquistWI
2003
Functional surfaces of the human immunodeficiency virus type 1 capsid protein.
J Virol
77
5439
5450
30. GambleTR
YooS
VajdosFF
von SchwedlerUK
WorthylakeDK
1997
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.
Science
278
849
853
31. AccolaMA
StrackB
GottlingerHG
2000
Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
J Virol
74
5395
5402
32. GanserBK
LiS
KlishkoVY
FinchJT
SundquistWI
1999
Assembly and analysis of conical models for the HIV-1 core.
Science
283
80
83
33. LiS
HillCP
SundquistWI
FinchJT
2000
Image reconstructions of helical assemblies of the HIV-1 CA protein.
Nature
407
409
413
34. BowzardJB
BennettRP
KrishnaNK
ErnstSM
ReinA
1998
Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.
J Virol
72
9034
9044
35. BurnistonMT
CimarelliA
ColganJ
CurtisSP
LubanJ
1999
Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
J Virol
73
8527
8540
36. OnoA
WaheedAA
JoshiA
FreedEO
2005
Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay.
J Virol
79
14131
14140
37. CimarelliA
SandinS
HoglundS
LubanJ
2000
Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
J Virol
74
3046
3057
38. MuriauxD
MirroJ
HarvinD
ReinA
2001
RNA is a structural element in retrovirus particles.
Proc Natl Acad Sci U S A
98
5246
5251
39. CampbellS
ReinA
1999
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
J Virol
73
2270
2279
40. CampbellS
VogtVM
1995
Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
J Virol
69
6487
6497
41. GrossI
HohenbergH
KrausslichHG
1997
In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.
Eur J Biochem
249
592
600
42. KhorchidA
HalwaniR
WainbergMA
KleimanL
2002
Role of RNA in facilitating Gag/Gag-Pol interaction.
J Virol
76
4131
4137
43. JouvenetN
SimonSM
BieniaszPD
2009
Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles.
Proc Natl Acad Sci U S A
106
19114
19119
44. MorikawaY
HockleyDJ
NermutMV
JonesIM
2000
Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.
J Virol
74
16
23
45. OnoA
DemirovD
FreedEO
2000
Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
J Virol
74
5142
5150
46. GuoX
RoldanA
HuJ
WainbergMA
LiangC
2005
Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag.
J Virol
79
1803
1812
47. LiangC
HuJ
WhitneyJB
KleimanL
WainbergMA
2003
A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1.
J Virol
77
1772
1783
48. DerdowskiA
DingL
SpearmanP
2004
A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
J Virol
78
1230
1242
49. LarsonDR
MaYM
VogtVM
WebbWW
2003
Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy.
J Cell Biol
162
1233
1244
50. LiH
DouJ
DingL
SpearmanP
2007
Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells.
J Virol
81
12899
12910
51. HogueIB
HoppeA
OnoA
2009
Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.
J Virol
83
7322
7336
52. HubnerW
ChenP
Del PortilloA
LiuY
GordonRE
2007
Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1.
J Virol
81
12596
12607
53. JinJ
SturgeonT
ChenC
WatkinsSC
WeiszOA
2007
Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.
J Virol
81
11226
11235
54. MilevMP
BrownCM
MoulandAJ
2010
Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1.
Retrovirology
7
41
55. DattaSA
ZhaoZ
ClarkPK
TarasovS
AlexandratosJN
2007
Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch.
J Mol Biol
365
799
811
56. RoldanA
RussellRS
MarchandB
GotteM
LiangC
2004
In vitro identification and characterization of an early complex linking HIV-1 genomic RNA recognition and Pr55Gag multimerization.
J Biol Chem
279
39886
39894
57. JouvenetN
BieniaszPD
SimonSM
2008
Imaging the biogenesis of individual HIV-1 virions in live cells.
Nature
454
236
240
58. RulliSJJr
HibbertCS
MirroJ
PedersonT
BiswalS
2007
Selective and nonselective packaging of cellular RNAs in retrovirus particles.
J Virol
81
6623
6631
59. GeisbergJV
StruhlK
2004
Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo.
Nucleic Acids Res
32
e151
60. Garbitt-HirstR
KenneySP
ParentLJ
2009
Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging.
J Virol
83
6790
6797
61. GudleskiN
FlanaganJM
RyanEP
BewleyMC
ParentLJ
2010
Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA.
Proc Natl Acad Sci U S A
107
9358
9363
62. KemlerI
MeehanA
2010
Poeschla EM Live cell co-imaging of the genomic RNAs and Gag proteins of two lentiviruses. (2010)
J Virol
84
6352
6366
63. MooreMD
NikolaitchikOA
ChenJ
HammarskjoldML
RekoshD
2009
Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses.
PLoS Pathog
5
e1000627
64. GomezCY
HopeTJ
2006
Mobility of human immunodeficiency virus type 1 Pr55Gag in living cells.
J Virol
80
8796
8806
65. PaillartJC
Shehu-XhilagaM
MarquetR
MakJ
2004
Dimerization of retroviral RNA genomes: an inseparable pair.
Nat Rev Microbiol
2
461
472
66. DurocherY
PerretS
KamenA
2002
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells.
Nucleic Acids Res
30
E9
67. Perez-CaballeroD
HatziioannouT
Martin-SerranoJ
BieniaszPD
2004
Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions.
J Virol
78
9560
9563
68. ZennouV
Perez-CaballeroD
GottlingerH
BieniaszPD
2004
APOBEC3G incorporation into human immunodeficiency virus type 1 particles.
J Virol
78
12058
12061
69. BaroniTE
ChitturSV
GeorgeAD
TenenbaumSA
2008
Advances in RIP-chip analysis : RNA-binding protein immunoprecipitation-microarray profiling.
Methods Mol Biol
419
93
108
70. PalmerS
WiegandAP
MaldarelliF
BazmiH
MicanJM
2003
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.
J Clin Microbiol
41
4531
4536
71. SpearmanP
HortonR
RatnerL
Kuli-ZadeI
1997
Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
J Virol
71
6582
6592
72. Simoes-BarbosaA
SantanaJM
TeixeiraAR
2000
Solubilization of delipidated macrophage membrane proteins for analysis by two-dimensional electrophoresis.
Electrophoresis
21
641
644
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 11
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Zn Inhibits Coronavirus and Arterivirus RNA Polymerase Activity and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
- The Female Lower Genital Tract Is a Privileged Compartment with IL-10 Producing Dendritic Cells and Poor Th1 Immunity following Infection
- Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41
- The Arabidopsis Resistance-Like Gene Is Activated by Mutations in and Contributes to Resistance to the Bacterial Effector AvrRps4